BKS Advisors’s Merck MRK Stock Holding History

BKS Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,138	Closed	-$187K	–	219
2016 Q3	$187K	Buy	+3,138	New	+$184K	0.09%	168

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BKS Advisors's MRK Position: Q4 2016 in Review

BKS Advisors sold out of Merck (MRK) in Q4 2016, closing a stake of 3,138 shares — an estimated $187K sold.

BKS Advisors first reported a position in MRK in Q3 2016 and held it in 1 quarter. The position peaked at $187K in Q3 2016. 1,912 funds tracked by Wall St. Rank hold MRK as of Q4 2016.

BKS Advisors reported no remaining Merck position as of Q4 2016 after selling out during the quarter.
BKS Advisors sold 3,138 Merck shares in Q4 2016, an estimated $187K.
BKS Advisors first reported a position in Merck in Q3 2016 and held it in 1 quarter.
BKS Advisors's Merck position peaked at $187K in Q3 2016.
1,912 funds tracked by Wall St. Rank held Merck as of Q4 2016.

Based on BKS Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.